{
    "clinical_study": {
        "@rank": "30286", 
        "arm_group": {
            "arm_group_label": "SNUBH-NM-333(18F), Safety, Efficacy", 
            "arm_group_type": "Experimental", 
            "description": "10 young controls, 10 cognitively normal elderly, and 10 Alzheimer's disease patients"
        }, 
        "brief_summary": {
            "textblock": "To evaluate pharmacokinetics, safety and efficacy of SNUBH-NM-333(18F), a new diagnostic\n      radiopharmaceutical for PET imaging of amyloid plaques, in Alzheimer's disease patients and\n      healthy volunteers."
        }, 
        "brief_title": "Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Alzheimer Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "detailed_description": {
            "textblock": "The investigators will perform whole-body and brain kinetic modeling of SNUBH-NM-333(18F)\n      and optimize the image acquisition procedure.\n\n      Five young healthy subjects will be participated in Whole-body positron emission tomography\n      /computed tomographic (PET/CT) scans from the midfemoral position to the head after\n      approximately 5-10 mCi of SNUBH-NM-333(18F) injection. For brain PET/CT amyloid imaging,\n      another five young healthy subjects will be scanned dynamically during windows of 0-180 min\n      after injection of SNUBH-NM-333(18F), with arterial sampling.\n\n      The investigators will compare different analysis methods of compartmental modeling and\n      standardized uptake value ratios and determine the optimal acquisition window. And then 10\n      AD patients and 10 elderly healthy controls will also be participated in brain amyloid\n      imaging to compare SNUBH-NM-333(18F) brain retention in AD patients versus healthy elderly."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy young controls who are 20 - 30 years old and have no subjective memrory\n             complaints\n\n          -  Cognitively normal elderly who have Clinical Dementia Rating score of 0\n\n          -  Alzheimer's disease (AD) patients who met both the DSM-IV criteria for dementia and\n             NINCDS-ADRDA criteria for probable AD\n\n        Exclusion Criteria:\n\n          -  any present serious medical, psychiatric, or neurological disorder that could affect\n             mental function; evidence of focal brain lesions on MRI; the presence of severe\n             behavioral or communication problems"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149017", 
            "org_study_id": "SNUBH-NM-333(18F)"
        }, 
        "intervention": {
            "arm_group_label": "SNUBH-NM-333(18F), Safety, Efficacy", 
            "description": "5-10 mCi", 
            "intervention_name": "SNUBH-NM-333(18F)", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "amyloid plaque", 
            "Positron-Emission Tomography", 
            "radiopharmaceuticals"
        ], 
        "lastchanged_date": "May 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 1 and Phase 2 Clinical Trials for the Evaluation of Pharmacokinetics, Safety, and Efficacy of SNUBH-NM-333(18F) in Alzheimer's Disease Patients and Healthy Volunteers.", 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital", 
            "last_name": "Sang Eun Kim, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "DVR = Distribution volume of region of interest/Distribution volume of reference region", 
            "measure": "Distribution volume ratio (DVR)", 
            "safety_issue": "No", 
            "time_frame": "Whole-body positron emission tomography /computed tomographic (PET/CT) scans will be performed within 30 days after screening."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149017"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Jong Inn Woo", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Standardized uptake value ratio (SUVr)", 
            "safety_issue": "No", 
            "time_frame": "Whole-body positron emission tomography /computed tomographic (PET/CT) scans will be performed within 30 days after screening."
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014", 
        "why_stopped": "SNUH-NM-333 ligand effect was judged to be insufficient."
    }
}